Gary K. Lee - Chief Scientific Officer at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

Gary K. Lee - trading volume in the past year for Lyell Immunopharma, Inc.

Holdings reported by Gary K. Lee for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16,938 $396,179 $23.39 11 Feb 2026 Direct
Option (right to buy) 50,000 10 Feb 2026 Direct Common Stock

Transactions reported by Gary K. Lee for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.